Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001711279-21-000018
Filing Date
2021-07-02
Accepted
2021-07-02 11:33:51
Documents
1
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162524001713056.html 4  
1 FORM 4 wf-form4_162524001713056.xml 4 3874
  Complete submission text file 0001711279-21-000018.txt   5220
Mailing Address 2525 DUPONT DRIVE IRVINE CA 92612
Business Address
Gangolli Julian S (Reporting) CIK: 0001532023 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38210 | Film No.: 211068574

Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Issuer) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)